97 results
Page 2 of 5
6-K
EX-10.3
d84lov7vl
21 Jul 23
Biophytis Announces $3.8 Million
6:01am
6-K
EX-10.4
ncj5wsg87528kr9swj
21 Jul 23
Biophytis Announces $3.8 Million
6:01am
424B5
nrkh3
20 Jul 23
Prospectus supplement for primary offering
5:27pm
6-K
EX-99.1
qvgerff
20 Jul 23
Current report (foreign)
11:35am
6-K
EX-99.1
84sawdy21
18 Jul 23
Biophytis and SEQENS sign a partnership to produce Sarconeos (BIO101) active compound
10:00am
6-K
3lree
26 May 23
Current report (foreign)
1:23pm
6-K
EX-99.1
swr gedluleeqc774by
26 May 23
Current report (foreign)
1:23pm
6-K
EX-99.1
eehesrc
9 May 23
Biophytis has requested a pre-submission meeting with the EMA for the Marketing Authorisation of Sarconeos (BIO101) for the treatment of COVID-19
2:35pm
6-K
EX-99.1
cq6lrafuh
2 May 23
Biophytis strengthens its management team
10:00am
6-K
EX-99.1
9gakrl7
2 May 23
Biophytis announces receipt of Nasdaq Notice
9:40am
F-3
u2g2 sncbwq91apsc
21 Apr 23
Shelf registration (foreign)
4:16pm
6-K
EX-99.1
fr4cs1n
18 Apr 23
Biophytis Announces 2022 Financial Results and 2023 Perspectives
11:35am
6-K
EX-99.1
cx8zfod hvi
4 Nov 22
Biophytis reports positive post-hoc analysis of the phase 2-3
6:02am
6-K
EX-99.1
vpyu5rmga o35iprj
2 Nov 22
Current report (foreign)
10:42am
6-K
EX-99.1
bvopsi4uyc5jvwt5jb
7 Sep 22
Current report (foreign)
10:49am